U.S. Food and Drug Administration Commissioner Scott Gottlieb is resigning, according to a person familiar with the matter, ending a tenure marked by a flood of new drugs and a push for sharp curbs on e-cigarette use.
Gottlieb, 46, had been in the middle of putting sharp new restrictions on electronic cigarettes, citing an “epidemic” of youth vaping that he said he feared could lead to new smokers.
Under his watch, approvals for totally new drugs soared to 59 in 2018 from just 22 in 2016, the last year of the Obama administration.
He was also a key part of the Trump administration’s push to lower drug costs. Those efforts focused on approving hundreds of new generic drugs, as well as targeting drug industry tactics he and others blamed for keeping prices high.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.